USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $-0.20 | $-0.17 | $-0.57 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $330.00K | $208.47K | $336.07M |
Invo Bioscience's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.17 | $-0.21 | $-0.13 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.78 | $-0.85 | $-0.72 |
| Dec 2022 | 2 | $-0.32 | $-0.55 | $-0.09 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.17 | $-0.09 | $-0.09 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.78 | $-0.66 | $-0.66 |
| Dec 2022 | 0 / 0 | $-0.32 | $-0.03 | $-0.03 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $880.00K | $800.00K | $960.00K |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $2.10M | $1.94M | $2.25M |
| Dec 2022 | 2 | $9.70M | $8.75M | $10.65M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $-0.20 | - | - |
| Aug 16, 2021 | Jun 2021 | $-0.19 | $-0.17 | 10.53% |
| May 17, 2021 | Mar 2021 | $-0.18 | $-0.25 | -42.86% |
| Mar 30, 2021 | Dec 2020 | $-0.24 | $-0.60 | -150.00% |
| Nov 16, 2020 | Sep 2020 | - | $-0.57 | - |
| Sep 30, 2020 | Jun 2020 | - | $-0.36 | - |
| Jun 30, 2020 | Mar 2020 | - | $-0.27 | - |
| Mar 31, 2020 | Dec 2019 | - | $-0.32 | - |
| Dec 31, 2019 | Sep 2019 | - | $-0.16 | - |
| Sep 30, 2019 | Jun 2019 | - | $-0.15 | - |
| May 15, 2019 | Mar 2019 | - | $-0.05 | - |
| Dec 31, 2018 | Dec 2018 | - | $-0.16 | - |
| Sep 30, 2018 | Sep 2018 | - | $-0.06 | - |
| Jun 30, 2018 | Jun 2018 | - | $-0.41 | - |
| Mar 31, 2018 | Mar 2018 | - | $-0.03 | - |
| Dec 31, 2017 | Dec 2017 | - | $-0.05 | - |
| Sep 30, 2017 | Sep 2017 | - | $-0.03 | - |
| Jun 30, 2017 | Jun 2017 | - | $-0.03 | - |
| Mar 31, 2017 | Mar 2017 | - | $-0.05 | - |
| Dec 31, 2016 | Dec 2016 | - | $-0.06 | - |
| Sep 30, 2016 | Sep 2016 | - | $-0.05 | - |
| Jun 30, 2016 | Jun 2016 | - | $-0.34 | - |
| Mar 31, 2016 | Mar 2016 | - | $-0.04 | - |
| Dec 31, 2015 | Dec 2015 | - | $-0.06 | - |
| Sep 30, 2011 | Sep 2011 | - | $-0.04 | - |
| Jun 30, 2011 | Jun 2011 | - | $-0.13 | - |
| Apr 15, 2011 | Mar 2011 | $-0.32 | $-0.64 | -100.00% |
| Dec 31, 2010 | Dec 2010 | $-0.32 | $-0.64 | -100.00% |
| Nov 22, 2010 | Sep 2010 | $-0.32 | $-0.00 | 98.84% |
| Aug 20, 2010 | Jun 2010 | $-0.32 | $-0.32 | - |
| Apr 6, 2010 | Mar 2010 | - | $0.29 | - |
| Dec 31, 2009 | Dec 2009 | - | $-0.32 | - |
| Sep 30, 2009 | Sep 2009 | - | $-2.02 | - |
| Jun 30, 2009 | Jun 2009 | - | $-0.26 | - |
| Mar 31, 2009 | Mar 2009 | - | $-0.39 | - |
| Dec 31, 2008 | Dec 2008 | - | $-1.05 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 30, 2021 | Dec 2020 | $-0.98 | $-1.81 | - |
| Mar 31, 2020 | Dec 2019 | - | $-0.68 | - |
| Dec 31, 2018 | Dec 2018 | - | $-0.66 | - |
| Dec 31, 2017 | Dec 2017 | - | $-0.16 | - |
| Dec 31, 2016 | Dec 2016 | - | $-0.49 | - |
| Dec 31, 2015 | Dec 2015 | - | $-0.86 | - |
| Dec 31, 2010 | Dec 2010 | - | $-0.67 | - |
| Dec 31, 2009 | Dec 2009 | - | $-2.99 | - |
| Dec 31, 2008 | Dec 2008 | - | $-1.05 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $330.00K | - | - |
| Aug 16, 2021 | Jun 2021 | $410.00K | $208.47K | 0.51% |
| May 17, 2021 | Mar 2021 | $590.00K | $196.57K | 0.33% |
| Mar 30, 2021 | Dec 2020 | $440.00K | $196.57K | 0.45% |
| Nov 16, 2020 | Sep 2020 | - | $336.07M | - |
| Sep 30, 2020 | Jun 2020 | - | $246.07K | - |
| Jun 30, 2020 | Mar 2020 | - | $258.57K | - |
| Mar 31, 2020 | Dec 2019 | - | $328.57K | - |
| Dec 31, 2019 | Sep 2019 | - | $303.57K | - |
| Sep 30, 2019 | Jun 2019 | - | $658.64K | - |
| May 15, 2019 | Mar 2019 | - | $189.43K | - |
| Dec 31, 2018 | Dec 2018 | - | $154.99K | - |
| Sep 30, 2018 | Sep 2018 | - | $125.03K | - |
| Jun 30, 2018 | Jun 2018 | - | - | - |
| Mar 31, 2018 | Mar 2018 | - | - | - |
| Dec 31, 2017 | Dec 2017 | - | $81.36K | - |
| Sep 30, 2017 | Sep 2017 | - | $68.22K | - |
| Jun 30, 2017 | Jun 2017 | - | - | - |
| Mar 31, 2017 | Mar 2017 | - | - | - |
| Dec 31, 2016 | Dec 2016 | - | $9.52K | - |
| Sep 30, 2016 | Sep 2016 | - | $17.83K | - |
| Jun 30, 2016 | Jun 2016 | - | - | - |
| Mar 31, 2016 | Mar 2016 | - | - | - |
| Dec 31, 2015 | Dec 2015 | - | - | - |
| Sep 30, 2011 | Sep 2011 | $50.00K | $12.88K | 0.26% |
| Jun 30, 2011 | Jun 2011 | $40.00K | - | - |
| Apr 15, 2011 | Mar 2011 | - | - | - |
| Dec 31, 2010 | Dec 2010 | - | $29.66K | - |
| Nov 22, 2010 | Sep 2010 | - | - | - |
| Aug 20, 2010 | Jun 2010 | - | - | - |
| Apr 6, 2010 | Mar 2010 | - | - | - |
| Dec 31, 2009 | Dec 2009 | - | $6.91K | - |
| Sep 30, 2009 | Sep 2009 | - | $2.85K | - |
| Jun 30, 2009 | Jun 2009 | - | - | - |
| Mar 31, 2009 | Mar 2009 | - | - | - |
| Dec 31, 2008 | Dec 2008 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 30, 2021 | Dec 2020 | $1.28M | $1.04M | -18.96% |
| Mar 31, 2020 | Dec 2019 | - | $1.48M | - |
| Dec 31, 2018 | Dec 2018 | - | $494.38K | - |
| Dec 31, 2017 | Dec 2017 | - | $282.14K | - |
| Dec 31, 2016 | Dec 2016 | - | $50.90K | - |
| Dec 31, 2015 | Dec 2015 | - | $11.69K | - |
| Dec 31, 2010 | Dec 2010 | - | $67.65K | - |
| Dec 31, 2009 | Dec 2009 | - | $63.20K | - |
| Dec 31, 2008 | Dec 2008 | - | $37.99K | - |
INVO's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 2 analysts, the average EPS estimation for Invo Bioscience's next quarterly earnings is $-0.20, with a low EPS estimation of $-0.22, and a high estimation of $-0.18.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.20, the last 2 month trend is $-0.13, and the 3 month trend is $-0.13.
Based on 2 analysts, the average revenue estimation is $330.00K, with a low revenue estimation of $250.00K, and a high estimation of $400.00K.
Invo Bioscience's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.
INVO's earnings per share (EPS) was $-0.17, beating the consensus analysts forecast of $-0.19 by 10.53%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -32.00%, and higher than the same period a year before (Jun 2020) by -52.78%.
Revenues were $208.47K, worse than the forecast of $410.00K by -49.15%, up by 6.05% from the previous quarter , and down by -15.28% from the same period last year.
The company reported a net income of $-1.82M.Free cash flow for the quarter was $-1.18M , compared to $-1.85M last quarter and $-1.16M a year before.
INVO ended the quarter with $1.70M in total debt, an increase of 119.63% compared to the previous quarter, and an increase of 56.12% compared to the same quarter a year before.
Invo Bioscience's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.
INVO's earnings per share (EPS) was $-1.81, missing the consensus analysts forecast of $-0.98 by 84.20% , and lower than the previous year's EPS (Dec 2019) by 167.44%.
Revenues were $1.04M, worse than the forecast of $1.28M by -18.96%, and down by -29.92% from previous year's revenue.
The company reported a net income of $-8.35M.
Invo Bioscience reported a free cash flow of $-4.86M for its fiscal year, compared to $1.26M a year ago.
The company ended the fiscal year with $775.02K in total debt, an increase of 106.14% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.